IDENTIFICATION OF CYS-150 IN THE ACTIVE-SITE OF PHOSPHOMANNOSE ISOMERASE FROM CANDIDA-ALBICANS

Candida albicans phosphomannose isomerase (PMI) (EC 5.3.1.8) has been recently cloned and overexpressed in Escherichia coli. The enzyme can be irreversibly inactivated by iodoacetate in 50 mM borate buffer, pH 9.0, in a time-dependent manner at a rate of 4.2 +/- 0.03 min-1 M-1. T his inhibition can be prevented by the substrate mannose 6-phosphate w ith a K(s) of 0.22 +/- 0.05 mM, slightly lower than its K(m) value. Ho wever, metals such as zinc and cadmium, which are reversible, competit ive inhibitors for PMI, do not protect the enzyme against modification . The protein has been labeled by using [2-C-14]iodoacetate, in the pr esence or absence of substrate, and the protein is fully inactivated w hen 1.0 thiol group is modified per molecule of enzyme. Tryptic maps o f the modified protein have been produced. The protected peptide has b een identified and sequenced, and the phenylthiohydantoin amino acids have been collected. The modified amino acidis Cys-150. This cysteine residue is conserved in mammalian and yeast phosphomannose isomerases, but not in bacterial species where it is replaced with asparagine. We therefore purified PMI from E. coli and showed that this enzyme is no t sensitive to inactivation by iodoacetate. The iodoacetate is presuma bly inhibiting PMI by sterically blocking the mannose 6-phosphate bind ing site. Multiple sequence alignment procedures were used to try to i dentify potential ligands of the zinc atom that is essential for enzym e activity and thus to delineate the active site region. There is a st rong homology between residues 130-140 in phosphomannose isomerase and the zinc binding site of copper-zinc superoxide dismutase, which cont ains two of the zinc ligands. This implies that the sequence 130-150 f orms a central part of the active site of the enzyme.